Entities / Company
Cocrystal Pharma.
company in Bothell, United States
- Reports this week
- 1
- Active events
- 1
- Connections
- 17
What's happening
Reports per dayLast 90 days
90 days agoDrag either end to show only events that began in that periodToday
Active this week
Earlier this month
One to three months ago
Gone quiet
No new reports in 90+ days-
Cocrystal Pharma presented Phase 1 clinical trial results at a Department of Defense medical conference.Some support1 report
-
Cocrystal Pharma filed an IND to proceed with US clinical trials, while the CDC estimated 685 million annual Norovirus cases.Some support2 reports
-
Cocrystal Pharma appointed James Martin as CFO and co-CEO on September 3, 2025.Well supported3 reports
No events began in the chosen period. Widen it, or reset.
Around Cocrystal Pharma this week
News at the entities that move Cocrystal Pharma most-
Bristol-Myers Squibb OperationalBristol-Myers Squibb is developing innovative treatments and supporting Cyprus' national effort in haematology.Moves Cocrystal Pharma
-
Gilead Sciences Mentioned togetherRequired regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.Moves Cocrystal Pharma
Connections
The 3 strongest of 17, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
James Martin Structural
James Martin holds the roles of CFO and co-CEO at Cocrystal Pharma.
-
Bristol-Myers Squibb Operational
The two companies are actively competing against each other for investment and market share in the healthcare sector.
-
Gilead Sciences Mentioned together
A historical personnel link was observed, indicating an executive gained experience at Gilead Sciences.
History
Events by the month they beganSeptember 2026
1 eventAugust 2026
2 eventsJune 2026
3 events- Cocrystal Pharma presented Phase 1 clinical trial results at a Department of Defense medical conference.
- Cocrystal Pharma filed an IND to proceed with US clinical trials, while the CDC estimated 685 million annual Norovirus cases.
- Cocrystal Pharma appointed James Martin as CFO and co-CEO on September 3, 2025.